Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses

被引:78
作者
Stephens, Geoffrey L. [1 ]
Andersson, John [1 ]
Shevach, Ethan M. [1 ]
机构
[1] NIAID, Cellular Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.178.11.6901
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Expression of the transcription factor FoxP3 is the hallmark of regulatory T cells that play a crucial role in dampening immune responses. A comparison of the development and phenotype of FoxP3(+) T cells in relation to the expression of conventional MHC molecules facilitated the identification of several distinct lineages of naive and effector/memory populations of Foxp3(+) T cells. One subpopulation of effector/memory Foxp3+ T cells develops in the thymic medulla, whereas the second is thymic independent. Both lineages display a distinct activated phenotype, undergo extensive steady-state proliferation, home to sites of acute inflammation, and are unique in their capacity to mediate Ag-nonspecific suppression of T cell activation directly ex vivo. Effector FoxP3(+) T cells may act as a sentinel of tolerance, providing a first line of defense against potentially harmful responses by rapidly suppressing immunity to peripheral self-Ags.
引用
收藏
页码:6901 / 6911
页数:11
相关论文
共 46 条
[1]   Essential role for CD103 in the T cell-mediated regulation of experimental colitis [J].
Annacker, O ;
Coombes, JL ;
Malmstrom, V ;
Uhlig, HH ;
Bourne, T ;
Johansson-Lindbom, B ;
Agace, WW ;
Parker, CM ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1051-1061
[2]   The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 [J].
Bennett, CL ;
Christie, J ;
Ramsdell, F ;
Brunkow, ME ;
Ferguson, PJ ;
Whitesell, L ;
Kelly, TE ;
Saulsbury, FT ;
Chance, PF ;
Ochs, HD .
NATURE GENETICS, 2001, 27 (01) :20-21
[3]   Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+ immunoregulatory T cells [J].
Bensinger, SJ ;
Bandeira, A ;
Jordan, MS ;
Caton, AJ ;
Laufer, TM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :427-438
[4]   Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity [J].
Bienvenu, B ;
Martin, B ;
Auffray, C ;
Cordier, C ;
Bécourt, C ;
Lucas, B .
JOURNAL OF IMMUNOLOGY, 2005, 175 (01) :246-253
[5]   ADHESION BETWEEN EPITHELIAL-CELLS AND T-LYMPHOCYTES MEDIATED BY E-CADHERIN AND THE ALPHA(E)BETA(7) INTEGRIN [J].
CEPEK, KL ;
SHAW, SK ;
PARKER, CM ;
RUSSELL, GJ ;
MORROW, JS ;
RIMM, DL ;
BRENNER, MB .
NATURE, 1994, 372 (6502) :190-193
[6]  
CEPEK KL, 1993, J IMMUNOL, V150, P3459
[7]   Where CD4+ CD25+ T reg cells impinge on autoimmune diabetes [J].
Chen, ZB ;
Herman, AE ;
Matos, M ;
Mathis, D ;
Benoist, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (10) :1387-1397
[8]   Cutting edge:: Self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells [J].
Cozzo, C ;
Larkin, J ;
Caton, AJ .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5678-5682
[9]   Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state [J].
Fisson, S ;
Darrasse-Jèze, G ;
Litvinova, E ;
Septier, F ;
Klatzmann, D ;
Liblau, R ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) :737-746
[10]   Developmental regulation of Foxp3 expression during ontogeny [J].
Fontenot, JD ;
Dooley, JL ;
Farr, AG ;
Rudensky, AY .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (07) :901-906